Knight Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.20 M
as on 04-12-2024
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.35 M
as on 04-12-2024
- Revenue 3.06%
(FY 2019)
- Profit -11.94%
(FY 2019)
- Ebitda -18.55%
(FY 2019)
- Net Worth -92.44%
(FY 2019)
- Total Assets -2.35%
(FY 2019)
About Knight Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹4.35 M.
Pallavi Hingnekar and Rahul Hingnekar serve as directors at the Company.
- CIN/LLPIN
U51397MH2002PTC134531
- Company No.
134531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Knight Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Hingnekar  | Director | 03-Oct-2024 | Current |
| Rahul Hingnekar | Whole-Time Director | 11-Jan-2002 | Current |
Financial Performance of Knight Pharmaceuticals.
Knight Pharmaceuticals Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 3.06% increase. The company also saw a substantial fall in profitability, with a 11.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 92.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Knight Pharmaceuticals?
In 2019, Knight Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2018 | ₹4.35 M | Open |
How Many Employees Work at Knight Pharmaceuticals?
Knight Pharmaceuticals has a workforce of 14 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Knight Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Knight Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
